Actinic Keratosis clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18-85
The study is a basic science research study that is designed to characterize and compare the immune response in individuals who are designated as ABO blood group secretors, meaning they have a functional copy of the FUT2 gene versus those patients who are designated ABO non-secretors after application of topical imiquimod to these patients.
at UC Davis
Our lead scientists for Actinic Keratosis research studies include Emanual Maverakis, MD.